The successful use of rituximab in children with IgA nephropathy and minimal change-like lesions: a case series.

Although the difference did not reach statistical significance ( p > 0.05), seven out of eight patients (87.5%) exhibited a prolongation of the relapse-free interval, with a mean prolongation of 5.5 months ( Figure 2 ).

also in 111,027 other papers